Cross-linking of antigen receptor via Ig-β (B29, CD79b) can induce both positive and negative signals in CD40-activated human B cells

Clinical and Experimental Immunology

Volumn 110, Issue 3, 1997, Pages 509-515

  Van Kooten, C ^a,c   Galibert, L ^a   Seon, B K ^b   Garrone, P ^a   Liu, Y J ^a   Banchereau, J ^a,d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

B cell; CD40; CD79b; Human

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2;

ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CELL DEATH; CROSS LINKING; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL;

EID: 0030734171     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4201436.x     Document Type: Article

References (40)

1. Rolink A, Melchers F. Molecular and cellular origins of B lymphocyte diversity. Cell 1991; 66:1081-94.
2. Reth M. Antigen receptors on B lymphocytes. Annu Rev Immunol 1992; 10:97-121.
3. Van Noesel CJM, Van Lier RAW. Architecture of the human B cell antigen receptor. Blood 1991; 82:363-73.
4. Cambier JC, Pleiman CM, Clark MR. Signal transduction by the B cell antigen receptor and its coreceptors. Annu Rev immunol 1994; 12:457-86.
5. Liu YJ, Johnson GD, Gordon J, MacLennan ICM. Germinal centres in T-cell-dependent antibody responses. Immunol Today 1992; 13:17-21.
6. Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12:881-922.
7. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994; 367:425-8.
8. Liu YJ, Banchereau J. The paths and molecular controls of peripheral B cell development. The Immunologist 1996; 4:55-66.
9. Dubois B, Vanbervliet B, Fayette J et al. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J Exp Med 1997; 185:941-51.
10. Van Kooten C, Banchereau J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 1996; 61:1-77.
11. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 1993; 14:559-64.
12. Notarangelo LD, Peitch MC. CD40Lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996; 17:511-6.
13. Kawabe T, Naka T, Yoshida K et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1:167-78.
14. Xu J, Foy TM, Laman JD et al. Mice deficient for the CD40 ligand. Immunity 1994; 1:423-31.
15. Goodnow CC. Transgenic mice and analysis of B cell tolerance. Annu Rev Immunol 1992; 10:489-518.
16. Nossal GJV. Negative selection of Imphocytes. Cell 1994; 76:229-39.
17. Mongini PKA, Blessinger C, Posnett DN, Rudich SM. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations. J Immunol 1989; 143:1565-74.
18. Kim KW, Ishigami T, Hata D et al. Anti-IgM but not anti-IgD antibodies inhibit cell division of normal human mature B cells. J Immunol 1992; 148:29-34.
19. Parry SL, Hasbold J, Holman M, Klaus GG. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol 1994; 152:2821-9.
20. Klinman NR. The 'clonal selection hypothesis' and current concepts of B cell tolerance. Immunity 1996; 5:189-95.
21. Galibert L, Burdin N, Barthelemy C et al. Negative selection of human germinal center B cells by prolonged BCR cross-linking. J Exp Med 1996; 183:2075-85.
22. Vasile S, Coligan JE, Yoshida M, Seon BK. Isolation and chemical characterization of the human B29 and MB-1 proteins of the B cell antigen receptor complex. Molec Immunol 1994; 31:419-7.
23. Okazaki M, Luo Y, Han T, Yoshida M, Seon BK. Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen. Blood 1993; 81:84-94.
24. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 1995; 182:1265-73.
25. Clark EA, Ledbetter JA. Activation of human B cells mediated through two distinct cell surface differentiation antigens. Bp35 and Bp50. Proc Natl Acad Sci USA 1986; 83:4494-8.
26. Valle A, Zuber CE, Defrance T, Djossou O, de Rie M, Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 1989; 19:1463-7.
27. Valentine MA, Licciardi KA. Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur J Immunol 1992; 22:3141-8.
28. Tsubata T, Wu J, Honjo T. B-cell apoptosis induced by antigen receptor triggering is blocked by a T cell signal through CD40. Nature 1993; 364:645-8.
29. Fulcher DA, Basten A. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med 1994; 179:125-34.
30. Cooke MP, Heath AW, Shokat KM et al. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med 1994; 179:425-38.
31. Eris JM, Basten A, Brink R, Doherty K, Kehry MR, Hodgkin PD. Anergic sell-reactive B cells present self antigen and respond normally to CD40-dependent T cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci USA 1994; 91:4392-6.
32. Linton PJ, Rudie A, Klinman NR. Tolerance susceptibility of newly generating memory B cells. J Immunol 1991; 146:4099-104.
33. Butch AW, Chung GH, Hoffman JW, Nahm MH. Cytokine expression by germinal center cells. J Immunol 1993; 150:39-47.
34. Lederman S, Yellin MJ, Inghirami G, Lee JJ, Knowles DM, Chess L. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 1992; 149:3817-26.
35. Galibert L, Burdin N, de Saint-Vis B et al. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J Exp Med 1996; 183:77-85.
36. Wheeler K, Gordon J. Co-ligation of surface IgM and CD40 on naive B lymphocytes generates a blast population with an ambiguous extra-follicular/germinal centre cell phenotype. Int Immunol 1996; 8:815-28.
37. Schattner EJ, Elkon KB, Yoo DH et al. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 1995; 182:1557-65.
38. Rothstein TL, Wang JKM, Panka DJ et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995; 374:163-5.
39. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: dual roles for CD40 and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996; 87:319-29.
40. Rothstein TL. Signals and susceptibility to programmed death in B cells. Curr Opin Immunol 1996; 8:362-71.